Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000239673 | SCV000950925 | uncertain significance | Congenital disorder of glycosylation, type IAA | 2023-10-18 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 290 of the NUS1 protein (p.Arg290His). This variant is present in population databases (no rsID available, gnomAD 0.003%). This missense change has been observed in individual(s) with NUS1-related conditions (PMID: 25066056, 36672771). ClinVar contains an entry for this variant (Variation ID: 253197). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects NUS1 function (PMID: 25066056, 34532305). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Institute of Human Genetics, |
RCV001253663 | SCV001429500 | uncertain significance | Intellectual disability, autosomal dominant 55, with seizures | 2018-02-06 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001262137 | SCV001439902 | pathogenic | Congenital disorder of glycosylation | 2019-01-01 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV000239673 | SCV002581702 | likely pathogenic | Congenital disorder of glycosylation, type IAA | 2022-08-02 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004701345 | SCV005204195 | likely pathogenic | NUS1-related disorder | 2024-06-20 | criteria provided, single submitter | clinical testing | Variant summary: NUS1 c.869G>A (p.Arg290His) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 250746 control chromosomes (gnomAD). c.869G>A has been reported in the literature in multiple homozygous individuals affected with NUS1-Related Disorders (Park_2014, Halfmeyer_2022). These data indicate that the variant is likely to be associated with disease. Publications also reported experimental evidence demonstrating decreased enzyme function in patient derived cells (Park_2014), as well as in an in vitro expression system (Grabinska_2017). The following publications have been ascertained in the context of this evaluation (PMID: 25066056, 36672771, 28842490). ClinVar contains an entry for this variant (Variation ID: 253197). Based on the evidence outlined above, the variant was classified as likely pathogenic. |
OMIM | RCV000239673 | SCV000297998 | pathogenic | Congenital disorder of glycosylation, type IAA | 2021-10-20 | no assertion criteria provided | literature only |